Neonatology
Masahiro Hayakawa, MD,PhD
Clinical Professor
Nagoya University Hospital
Nagoya, Japan
Charles Cotten, MD MHS
Professor
Pediatrics
Duke University
Duke University
Durham, North Carolina, United States
Despite recent advances in neonatal intensive care medicine, several neonatal disorders remain major causes of mortality and morbidities. Few effective therapies are currently available to ameliorate the injuries resulting from these disorders. Therefore, developing new safe and effective therapies to improve the outcomes of these disorders is an urgent and considerable issue. Recently, various preclinical studies have shown that stem cell therapy significantly attenuates injuries in newborn animal models of neonatal complications. These findings suggest that stem cell therapy/regenerative therapy might represent the next breakthrough in therapy of these currently intractable and devastating neonatal disorders. In this session, we focus on the results of preclinical/clinical research in several neonatal complications.
Presenter: Bernard Thebaud, MD, PhD – Ottawa Hospital Research Institute
Presenter: Yoshiaki Sato, MD, PhD – Nagoya University Hospital
Presenter: Dezhi Mu, MD – West China Second Hospital of Sichuan University
Presenter: Roger De Filippo, MD – Children's Hospital Los Angeles
Presenter: -- --
Presenter: -- --